Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Journal of Bone and Mineral Metabolism|October 3, 2025
One-year bone mineral density gains with anti-osteoporotic medications and clinical factors associated with non-BMD gainersSeol A Jang, Seok-Jae Heo, Su Jin Kwon, et al.
Pituitary|October 29, 2010
Carotid atheromatic plaque is commonly associated with hypopituitary menJoo Young Kim, Jae Won Hong, Sang Youl Rhee, et al.
Anticancer Research|November 7, 2018
Evodiamine Suppresses Survival, Proliferation, Migration and Epithelial-Mesenchymal Transition of Thyroid Carcinoma CellsSi Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Journal of Diabetes and Its Complications|August 2, 2015
Can increased visceral adiposity without body weight changes accelerate carotid atherosclerosis in South Korean participants with type 2 diabetes?Chul Sik Kim, Soo-Kyung Kim, Maria Rosario G Araneta, et al.
Diabetes & Metabolism Journal|April 30, 2016
Glycosylated Hemoglobin Threshold for Predicting Diabetes and Prediabetes from the Fifth Korea National Health and Nutrition Examination SurveySangmo Hong, Jun Goo Kang, Chul Sik Kim, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 30, 2016
Synergistic cytotoxicity of BIIB021 with triptolide through suppression of PI3K/Akt/mTOR and NF-κB signal pathways in thyroid carcinoma cellsSi Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 7, 2017
The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cellsSi Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Endocrine|December 30, 2017
Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cellsSi Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 2, 2017
Cytotoxic effect of celastrol alone or in combination with paclitaxel on anaplastic thyroid carcinoma cellsSi Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Biochemical and Biophysical Research Communications|December 3, 2014
Herbimycin A inhibits cell growth with reversal of epithelial-mesenchymal transition in anaplastic thyroid carcinoma cellsSi Hyoung Kim, Jun Goo Kang, Chul Sik Kim, et al.
Pageof 8